
Kezar Life Sciences, Inc.
USD7.29
+0.00 (+0.00%)
CEO
Christopher J. Kirk
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.29
Prev. Close
$7.29
Day Low
$7.29
Day High
$7.29
52W Low
$3.53
52W High
$7.55
Market Cap
$0.05B
| 16 Jul 2025 |
| HC Wainwright & Co. |
| Neutral |
| Neutral |
| maintain |
| 19 Dec 2024 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 2 Dec 2024 | HC Wainwright & Co. | Neutral | Neutral | maintain |
| 14 Nov 2024 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 2 Oct 2024 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 14 Aug 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 22 Jul 2024 | HC Wainwright & Co. | Buy | Buy | maintain |